MedPath

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

Completed
Conditions
Bacterial Infection
Registration Number
NCT01173575
Lead Sponsor
Infectopharm Arzneimittel GmbH
Brief Summary

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection.

Primary objective:

• To assess clinical and microbiological efficacy of FOM in patients with bacterial infection.

Secondary objectives:

* To determine the rate and severity of unexpected adverse events.

* To determine the mean duration of therapy with FOM in patients with bacterial infection.

Study design:

Multi-center, non-interventional study

Detailed Description

Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J\&P MEDICAL RESEARCH LTD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
209
Inclusion Criteria
  • Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

Medical University Graz

🇦🇹

Graz, Styria, Austria

University Hospital Tübingen

🇩🇪

Tübingen, Baden-Württemberg, Germany

Augsburg Hospital

🇩🇪

Augsburg, Bavaria, Germany

Kreisklinik Guenzburg Krumbach

🇩🇪

Krumbach, Bavaria, Germany

University Hospital Regensburg

🇩🇪

Regensburg, Bavaria, Germany

Weiden Hospital

🇩🇪

Weiden In Der Oberpfalz, Bavaria, Germany

University Hospital Munich

🇩🇪

Munich, Bayern, Germany

University Hospital Frankfurt

🇩🇪

Frankfurt, Hessen, Germany

Evangelische Krankenhausstiftung Oldenburg

🇩🇪

Oldenburg, Lower Saxony, Germany

Klinikum Oldenburg gGmbH

🇩🇪

Oldenburg, Lower Saxony, Germany

Scroll for more (15 remaining)
Medical University Graz
🇦🇹Graz, Styria, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.